Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. (HARP) Revenue
Annual & quarterly revenue history · segment & region breakdown
HARP · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsHarpoon Therapeutics, Inc. trailing twelve-month (TTM) revenue is $0.04B, an increase of 34.92% year-over-year from $0.03B in FY2022.
Revenue trend
2022 – 2016 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.03B | +$0.01B | +34.92% |
| 2021-12-31 | $0.02B | +$0.01B | +35.60% |
| 2020-12-31 | $0.02B | +$0.01B | +201.96% |
| 2019-12-31 | $0.01B | +$0.00B | +21.62% |
| 2018-12-31 | $0.00B | +$0.00B | +570.90% |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Harpoon Therapeutics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Harpoon Therapeutics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Harpoon Therapeutics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HARP revenue · 4 questionsHARP's trailing twelve-month (TTM) revenue is $0.04B. That is an increase of 34.92% year-over-year from $0.03B in FY2022.
▸ Source: FMP · Harpoon Therapeutics, Inc. SEC filings · GAAP · Harpoon Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026